Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- RAG induction and V(D)J recombination
- Somatic recombination of TCR genes
- Two TCR-based lineages: αβ and γδ T cells
- Decision #2: αβ or γδ T cell?
- Studying T cell development with mouse models
- T cell subset selection in the mouse thymus
- Surrogate pTα and the pre-TCR
- Downstream signalling from pre-TCR to the nucleus
- Signal strength model for αβ/γδ lineage commitment (1)
- Signal strength model for αβ/γδ lineage commitment (2)
- Notch and the pre-TCR dictate the fate of T cells
- Critical role of the pre-TCR in αβ T cell development
- Major checkpoints in αβ T cell development
- Selection of thymocytes on MHC & self peptide
- Decision #3: CD4+ or CD8+ αβ T cell? (1)
- Decision #3: CD4+ or CD8+ αβ T cell? (2)
- Duration of signal determines αβ T cell type
- Overview of T cell development so far
- Decision #4: Tconv or Treg CD4+ αβ T cell?
- TCR signal strength
- Decision #5: γδIFN or γδ17 T cell?
- Developmental pre-programming of γδ T cells
- TCR signal strength models for αβ and γδ T cells
- γδ T cell subsets in the tumour microenvironment
- Acknowledgements
- Summary
Topics Covered
- Somatic recombination of TCR genes
- αβ and γδ T cell differentiation
- The pre-TCR
- CD4+ or CD8+ αβ T cell lineage?
- Determinants of Tconv or Treg T cell development
- γδIFN or γδ17 T cell development?
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Silva-Santos, B. (2021, December 26). Lineage decisions in the thymus: αβ and γδ T cell lineages [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/BQQA2576.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Bruno Silva-Santos has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Lineage decisions in the thymus: αβ and γδ T cell lineages
Published on December 26, 2021
35 min
Other Talks in the Series: The Immune System - Key Concepts and Questions
Transcript
Please wait while the transcript is being prepared...
0:03
After IL-7 and IL-7 receptor provide the survival signals to early pro-T-cells,
the major event in T-cell development occurs,
which is the rearrangement of the T-cell receptor genes.
The T-cell receptor characterizes T-cells, this is what's different between a T-cell
and the other lineages of immune cells, so the rearrangement of the T-cell
receptor genes, and the expression of the T-cell receptor,
is the key event that will take place in the thymus.
This is dependent on a key enzyme called RAG, recombination activating
gene, is the enzyme that orchestrates the rearrangement of the T-cell receptor
genes, so once again, children that have mutations in RAG will have another type
of SCID (severe combined immunodeficiency).
In this case it's called Omenn syndrome, after the person who identified it,
and it means the absence of both T- and B-cells.
In contrast with X-linked SCID described in the previous slide - where T-cells were
absent but B-cells were there - in this case, because RAG is not expressed,
and RAG is required for both B- and T-cell development, the child will be devoid
of both B- and T-cells.
This will result in an even more aggressive immunodeficiency.
In this case, once again, bone marrow transplantation will be required, so that
the child can develop normal B- and T-cells, once it gets healthy bone marrow
with healthy T- and B-cell progenitors that can express the RAG protein.
What does RAG do?